| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.766 | 0.021 | 0.796 | Apoptosis agonist | 0.796 0.017 CID_154699583 | CID_154699583 | |
| 0.736 | 0.005 | 0.736 | Nitric oxide antagonist | 0.717 0.005 CID_154699583 | ||
| 0.736 | 0.024 | 0.849 | Antiinflammatory | 0.849 0.009 CID_154699583 | CID_154699583 | |
| 0.644 | 0.005 | 0.644 | Antimitotic | 0.295 0.045 CID_154699583 | ||
| 0.58 | 0.016 | 0.639 | Immunosuppressant | 0.639 0.009 CID_154699583 | CID_154699583 | |
| 0.589 | 0.033 | 0.788 | Transcription factor NF kappa B inhibitor | 0.788 0.014 CID_154699583 | CID_154699583 | |
| 0.556 | 0.01 | 0.595 | Tumour necrosis factor alpha release inhibitor | 0.595 0.008 CID_154699583 | CID_154699583 | |
| 0.567 | 0.041 | 0.682 | Caspase 9 stimulant | 0.682 0.026 CID_154699583 | CID_154699583 | |
| 0.511 | 0.004 | 0.511 | Lipocortins synthesis antagonist | 0.353 0.013 CID_154699583 | ||
| 0.536 | 0.028 | 0.536 | Aldehyde oxidase inhibitor | |||
| 0.51 | 0.019 | 0.646 | Apoptosis antagonist | 0.646 0.005 CID_154699583 | CID_154699583 | |
| 0.483 | 0.005 | 0.483 | Sodium/bile acid cotransporter inhibitor | 0.373 0.027 CID_154699583 | ||
| 0.468 | 0.035 | 0.468 | Vasodilator, peripheral | 0.385 0.06 CID_154699583 | ||
| 0.445 | 0.041 | 0.695 | Cholesterol antagonist | 0.695 0.008 CID_154699583 | CID_154699583 | |
| 0.404 | 0.016 | 0.404 | P-glycoprotein inhibitor | 0.265 0.037 CID_154699583 | ||
| 0.44 | 0.06 | 0.696 | Antibacterial | 0.696 0.009 CID_154699583 | CID_154699583 | |
| 0.393 | 0.027 | 0.393 | Calcium channel activator | |||
| 0.37 | 0.013 | 0.503 | Interferon gamma antagonist | 0.503 0.006 CID_154699583 | CID_154699583 | |
| 0.397 | 0.046 | 0.433 | 5 Hydroxytryptamine release stimulant | 0.433 0.039 CID_154699583 | CID_154699583 | |
| 0.363 | 0.017 | 0.486 | Platelet adhesion inhibitor | 0.486 0.005 CID_154699583 | CID_154699583 | |
| 0.366 | 0.021 | 0.366 | Growth hormone agonist | |||
| 0.365 | 0.021 | 0.365 | Anesthetic general | 0.323 0.028 CID_154699583 | ||
| 0.378 | 0.039 | 0.657 | Antioxidant | 0.657 0.008 CID_154699583 | CID_154699583 | |
| 0.356 | 0.024 | 0.356 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.313 | 0.004 | 0.313 | Vasopressin 1 antagonist | |||
| 0.326 | 0.023 | 0.597 | Hepatoprotectant | 0.597 0.005 CID_154699583 | CID_154699583 | |
| 0.303 | 0.003 | 0.303 | Adenylate cyclase stimulant | 0.204 0.012 CID_154699583 | ||
| 0.385 | 0.088 | 0.452 | 5 Hydroxytryptamine release inhibitor | 0.452 0.051 CID_154699583 | CID_154699583 | |
| 0.303 | 0.016 | 0.344 | Alpha-N-acetylglucosaminidase inhibitor | 0.344 0.012 CID_154699583 | CID_154699583 | |
| 0.284 | 0.004 | 0.284 | Oxytocin antagonist | 0.058 0.015 CID_154699583 | ||
| 0.279 | 0.004 | 0.279 | Vasopressin 1A antagonist | |||
| 0.282 | 0.014 | 0.282 | Cholesterol synthesis inhibitor | 0.202 0.026 CID_154699583 | ||
| 0.261 | 0.006 | 0.261 | Microtubule formation inhibitor | 0.259 0.006 CID_154699583 | ||
| 0.322 | 0.071 | 0.433 | Vasodilator, coronary | 0.433 0.026 CID_154699583 | CID_154699583 | |
| 0.255 | 0.005 | 0.255 | Arachidonic acid antagonist | 0.199 0.034 CID_154699583 | ||
| 0.27 | 0.022 | 0.27 | Phospholipase C inhibitor | 0.161 0.086 CID_154699583 | ||
| 0.301 | 0.056 | 0.301 | Cardiotonic | |||
| 0.291 | 0.047 | 0.435 | DNA synthesis inhibitor | 0.435 0.018 CID_154699583 | CID_154699583 | |
| 0.27 | 0.028 | 0.27 | Neurotrophic factor enhancer | 0.25 0.039 CID_154699583 | ||
| 0.282 | 0.047 | 0.282 | Gastrin inhibitor | 0.247 0.082 CID_154699583 | ||
| 0.238 | 0.005 | 0.238 | Antidiuretic hormone antagonist | |||
| 0.241 | 0.013 | 0.241 | Farnesoid X receptor antagonist | |||
| 0.227 | 0.006 | 0.227 | Pregnane X receptor agonist | |||
| 0.305 | 0.085 | 0.655 | Antithrombotic | 0.655 0.011 CID_154699583 | CID_154699583 | |
| 0.297 | 0.079 | 0.511 | Immunostimulant | 0.511 0.028 CID_154699583 | CID_154699583 | |
| 0.233 | 0.02 | 0.233 | DNA polymerase I inhibitor | 0.217 0.023 CID_154699583 | ||
| 0.242 | 0.029 | 0.361 | Protein kinase stimulant | 0.361 0.011 CID_154699583 | CID_154699583 | |
| 0.218 | 0.008 | 0.252 | Transcription factor NF kappa B stimulant | 0.252 0.005 CID_154699583 | CID_154699583 | |
| 0.267 | 0.067 | 0.421 | Interleukin agonist | 0.421 0.016 CID_154699583 | CID_154699583 | |
| 0.203 | 0.004 | 0.203 | Anabolic | 0.152 0.017 CID_154699583 | ||
| 0.284 | 0.086 | 0.433 | Interleukin 2 agonist | 0.433 0.019 CID_154699583 | CID_154699583 | |
| 0.248 | 0.05 | 0.248 | RNA-directed DNA polymerase inhibitor | 0.236 0.059 CID_154699583 | ||
| 0.208 | 0.012 | 0.208 | Estrogen antagonist | 0.111 0.073 CID_154699583 | ||
| 0.275 | 0.08 | 0.341 | Hypoxia-inducible factor 1 alpha inhibitor | 0.341 0.048 CID_154699583 | CID_154699583 | |
| 0.24 | 0.047 | 0.24 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.257 | 0.067 | 0.751 | Angiogenesis stimulant | 0.751 0.004 CID_154699583 | CID_154699583 | |
| 0.192 | 0.003 | 0.192 | Vasopressin 2 antagonist | 0.036 0.02 CID_154699583 | ||
| 0.199 | 0.014 | 0.199 | Androgen antagonist | |||
| 0.193 | 0.008 | 0.193 | Estrogen agonist | 0.118 0.014 CID_154699583 | ||
| 0.254 | 0.072 | 0.254 | Superoxide dismutase inhibitor | |||
| 0.206 | 0.024 | 0.206 | Adenylate cyclase inhibitor | 0.093 0.091 CID_154699583 | ||
| 0.274 | 0.094 | 0.304 | Caspase 3 stimulant | 0.304 0.076 CID_154699583 | CID_154699583 | |
| 0.183 | 0.005 | 0.183 | Androgen agonist | 0.065 0.036 CID_154699583 | ||
| 0.178 | 0.008 | 0.178 | Ca2+-transporting ATPase inhibitor | 0.175 0.01 CID_154699583 | ||
| 0.252 | 0.082 | 0.252 | Transcription factor STAT3 inhibitor | |||
| 0.193 | 0.026 | 0.193 | CF transmembrane conductance regulator agonist | |||
| 0.17 | 0.005 | 0.17 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | |||
| 0.202 | 0.04 | 0.252 | NOS3 expression enhancer | 0.252 0.026 CID_154699583 | CID_154699583 | |
| 0.165 | 0.004 | 0.165 | RNA-directed RNA polymerase stimulant | 0.146 0.004 CID_154699583 | ||
| 0.185 | 0.024 | 0.314 | Antineoplastic antibiotic | 0.314 0.009 CID_154699583 | CID_154699583 | |
| 0.169 | 0.012 | 0.169 | Keratolytic | |||
| 0.174 | 0.021 | 0.174 | Antineoplastic alkaloid | |||
| 0.195 | 0.043 | 0.318 | Melanin inhibitor | 0.318 0.02 CID_154699583 | CID_154699583 | |
| 0.164 | 0.011 | 0.164 | Aromatase inhibitor | |||
| 0.232 | 0.091 | 0.232 | DNA damaging | 0.23 0.093 CID_154699583 | ||
| 0.147 | 0.006 | 0.16 | Na+ K+ transporting ATPase inhibitor | 0.16 0.004 CID_154699583 | CID_154699583 | |
| 0.142 | 0.003 | 0.142 | Heme oxygenase stimulant | 0.1 0.007 CID_154699583 | ||
| 0.151 | 0.011 | 0.151 | Estrogen receptor alpha antagonist | |||
| 0.147 | 0.008 | 0.161 | Glycine receptor antagonist | 0.161 0.005 CID_154699583 | CID_154699583 | |
| 0.168 | 0.029 | 0.367 | Expectorant | 0.367 0.005 CID_154699583 | CID_154699583 | |
| 0.163 | 0.025 | 0.287 | UDP-glucose 4-epimerase inhibitor | 0.287 0.011 CID_154699583 | CID_154699583 | |
| 0.191 | 0.057 | 0.191 | Succinate dehydrogenase inhibitor | |||
| 0.148 | 0.016 | 0.148 | Estrogen receptor beta antagonist | |||
| 0.272 | 0.14 | 0.521 | Histamine release inhibitor | 0.521 0.022 CID_154699583 | CID_154699583 | |
| 0.315 | 0.192 | 0.315 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.131 | 0.008 | 0.131 | Estrogen receptor beta agonist | |||
| 0.124 | 0.003 | 0.124 | Adenylate cyclase 1 inhibitor | |||
| 0.124 | 0.006 | 0.124 | Estrogen receptor alpha agonist | |||
| 0.143 | 0.029 | 0.157 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.157 0.024 CID_154699583 | CID_154699583 | |
| 0.142 | 0.029 | 0.142 | Adenylate kinase inhibitor | |||
| 0.122 | 0.012 | 0.122 | Glycine receptor agonist | 0.112 0.015 CID_154699583 | ||
| 0.143 | 0.036 | 0.146 | Mucolytic | 0.146 0.034 CID_154699583 | CID_154699583 | |
| 0.129 | 0.023 | 0.223 | Phosphofructokinase-1 inhibitor | 0.223 0.009 CID_154699583 | CID_154699583 | |
| 0.219 | 0.113 | 0.219 | Transcription factor STAT inhibitor | |||
| 0.113 | 0.009 | 0.113 | 5-Alpha-reductase inhibitor | 0.041 0.023 CID_154699583 | ||
| 0.121 | 0.018 | 0.121 | Bile acid receptor antagonist | |||
| 0.189 | 0.087 | 0.204 | Psychostimulant | 0.204 0.078 CID_154699583 | CID_154699583 | |
| 0.14 | 0.039 | 0.165 | CC chemokine 6 receptor antagonist | 0.165 0.009 CID_154699583 | CID_154699583 | |
| 0.126 | 0.027 | 0.126 | ABCA1 expression enhancer | |||
| 0.104 | 0.004 | 0.104 | Farnesoid X receptor agonist | |||
| 0.196 | 0.097 | 0.267 | Hypolipemic | 0.267 0.06 CID_154699583 | CID_154699583 | |
| 0.103 | 0.004 | 0.103 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.075 0.005 CID_154699583 | ||
| 0.127 | 0.029 | 0.185 | Triose-phosphate isomerase inhibitor | 0.185 0.013 CID_154699583 | CID_154699583 | |
| 0.147 | 0.051 | 0.271 | Cyclooxygenase 3 inhibitor | 0.271 0.007 CID_154699583 | CID_154699583 | |
| 0.211 | 0.117 | 0.211 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.134 | 0.041 | 0.134 | GABA C receptor agonist | |||
| 0.102 | 0.01 | 0.102 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.202 | 0.111 | 0.622 | Hypoglycemic | 0.622 0.007 CID_154699583 | CID_154699583 | |
| 0.108 | 0.017 | 0.108 | Estrogen-related receptor beta agonist | |||
| 0.096 | 0.006 | 0.096 | Lipocortins synthesis agonist | 0.087 0.01 CID_154699583 | ||
| 0.192 | 0.103 | 0.192 | Nitric-oxide synthase stimulant | 0.19 0.106 CID_154699583 | ||
| 0.093 | 0.009 | 0.093 | Aldosterone antagonist | |||
| 0.114 | 0.03 | 0.114 | Ornithine decarboxylase inhibitor | 0.087 0.059 CID_154699583 | ||
| 0.095 | 0.011 | 0.095 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.112 | 0.028 | 0.145 | Glutamate release inhibitor | 0.145 0.011 CID_154699583 | CID_154699583 | |
| 0.127 | 0.043 | 0.226 | AMP-activated protein kinase stimulant | 0.226 0.008 CID_154699583 | CID_154699583 | |
| 0.114 | 0.032 | 0.164 | NADH dehydrogenase inhibitor | 0.164 0.015 CID_154699583 | CID_154699583 | |
| 0.085 | 0.004 | 0.085 | Microtubule stabilization | 0.066 0.009 CID_154699583 | ||
| 0.098 | 0.019 | 0.098 | Alcohol oxidase inhibitor | |||
| 0.084 | 0.005 | 0.084 | Pregnane X receptor antagonist | |||
| 0.093 | 0.014 | 0.093 | Glutamate (mGluR6) antagonist | |||
| 0.143 | 0.067 | 0.293 | Amylase inhibitor | 0.293 0.019 CID_154699583 | CID_154699583 | |
| 0.101 | 0.027 | 0.101 | CDC25A inhibitor | |||
| 0.175 | 0.102 | 0.175 | Insulin sensitizer | |||
| 0.188 | 0.116 | 0.418 | Peptidyltransferase inhibitor | 0.418 0.006 CID_154699583 | CID_154699583 | |
| 0.078 | 0.007 | 0.078 | Glucocorticoid antagonist | |||
| 0.131 | 0.061 | 0.131 | Aldehyde dehydrogenase inhibitor | |||
| 0.079 | 0.011 | 0.079 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.234 | 0.169 | 0.234 | GABA C receptor rho-3 antagonist | |||
| 0.089 | 0.024 | 0.089 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.087 | 0.023 | 0.087 | Argininosuccinate synthase inhibitor | |||
| 0.117 | 0.055 | 0.117 | GABA C receptor antagonist | |||
| 0.065 | 0.004 | 0.065 | Tubulin agonist | 0.038 0.017 CID_154699583 | ||
| 0.074 | 0.014 | 0.121 | Alpha-mannosidase inhibitor | 0.121 0.005 CID_154699583 | CID_154699583 | |
| 0.065 | 0.008 | 0.067 | Guanylate cyclase inhibitor | 0.067 0.006 CID_154699583 | CID_154699583 | |
| 0.057 | 0.001 | 0.071 | Telomerase stimulant | 0.071 0.001 CID_154699583 | CID_154699583 | |
| 0.069 | 0.013 | 0.079 | Glucose-6-phosphate isomerase inhibitor | 0.079 0.009 CID_154699583 | CID_154699583 | |
| 0.06 | 0.005 | 0.06 | Vasopressin 1B antagonist | |||
| 0.116 | 0.062 | 0.155 | Photosensitizer | 0.155 0.028 CID_154699583 | CID_154699583 | |
| 0.106 | 0.053 | 0.106 | Creatine kinase inhibitor | |||
| 0.126 | 0.074 | 0.126 | Vanilloid 1 agonist | 0.126 0.073 CID_154699583 | ||
| 0.059 | 0.007 | 0.059 | Glucose-6-phosphate dehydrogenase inhibitor | 0.035 0.032 CID_154699583 | ||
| 0.116 | 0.064 | 0.116 | TRPA1 agonist | |||
| 0.257 | 0.205 | 0.711 | Cyclophilin D inhibitor | 0.711 0.013 CID_154699583 | CID_154699583 | |
| 0.058 | 0.009 | 0.058 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.102 | 0.053 | 0.102 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.062 | 0.014 | 0.062 | Progesterone antagonist | |||
| 0.112 | 0.065 | 0.112 | Cystathionine beta-synthase inhibitor | |||
| 0.086 | 0.039 | 0.086 | Glutamate dehydrogenase inhibitor | |||
| 0.169 | 0.125 | 0.488 | Free radical scavenger | 0.488 0.017 CID_154699583 | CID_154699583 | |
| 0.069 | 0.026 | 0.069 | Botulinum neurotoxin type A inhibitor | |||
| 0.078 | 0.038 | 0.078 | Phospholipase D inhibitor | |||
| 0.067 | 0.029 | 0.067 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.057 | 0.019 | 0.105 | Mannosidase inhibitor | 0.105 0.005 CID_154699583 | CID_154699583 | |
| 0.041 | 0.004 | 0.041 | Hedgehog signaling activator | |||
| 0.078 | 0.044 | 0.078 | Vanilloid 4 agonist | |||
| 0.092 | 0.058 | 0.092 | Potassium channel activator | |||
| 0.041 | 0.009 | 0.041 | Glutamate (mGluR3) agonist | |||
| 0.064 | 0.033 | 0.064 | Sphingosine kinase inhibitor | |||
| 0.038 | 0.007 | 0.038 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.122 | 0.091 | 0.311 | Lipid peroxidase inhibitor | 0.311 0.017 CID_154699583 | CID_154699583 | |
| 0.122 | 0.092 | 0.122 | Neurotrophic factor | |||
| 0.109 | 0.079 | 0.185 | Alkylator | 0.185 0.031 CID_154699583 | CID_154699583 | |
| 0.172 | 0.143 | 0.206 | Spasmolytic | 0.206 0.114 CID_154699583 | CID_154699583 | |
| 0.084 | 0.056 | 0.084 | Inducible nitric-oxide synthase inhibitor | |||
| 0.057 | 0.03 | 0.057 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.035 | 0.01 | 0.035 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.048 | 0.025 | 0.048 | Parathyroid hormone antagonist | |||
| 0.051 | 0.029 | 0.051 | Potassium channel Kv1.3 blocker | |||
| 0.031 | 0.009 | 0.031 | 5-Alpha-reductase 2 inhibitor | |||
| 0.039 | 0.018 | 0.039 | Ceramide glucosyltransferase inhibitor | |||
| 0.135 | 0.114 | 0.221 | Interleukin 6 antagonist | 0.221 0.031 CID_154699583 | CID_154699583 | |
| 0.055 | 0.035 | 0.055 | Alpha tubulin antagonist | |||
| 0.043 | 0.024 | 0.043 | Kainate receptor agonist | |||
| 0.057 | 0.038 | 0.057 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.029 | 0.011 | 0.046 | Vanilloid 2 agonist | 0.046 0.003 CID_154699583 | CID_154699583 | |
| 0.131 | 0.115 | 0.131 | Heat shock protein 70 antagonist | |||
| 0.026 | 0.01 | 0.026 | Corticosteroid-like | 0.026 0.009 CID_154699583 | ||
| 0.049 | 0.033 | 0.049 | HCV NS3/NS4A protease inhibitor | |||
| 0.021 | 0.005 | 0.021 | Thromboxane A2 agonist | |||
| 0.042 | 0.027 | 0.042 | Thymidine kinase inhibitor | |||
| 0.025 | 0.01 | 0.025 | Vitamin D receptor antagonist | 0.021 0.016 CID_154699583 | ||
| 0.031 | 0.016 | 0.031 | Purinergic P2Y15 antagonist | |||
| 0.022 | 0.008 | 0.024 | Ileal bile acid transport inhibitor | 0.024 0.007 CID_154699583 | CID_154699583 | |
| 0.028 | 0.014 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.035 | 0.022 | 0.035 | HMG CoA reductase inhibitor | |||
| 0.041 | 0.028 | 0.041 | Liver X receptor alpha agonist | |||
| 0.019 | 0.007 | 0.019 | Vitamin D receptor agonist | 0.015 0.014 CID_154699583 | ||
| 0.03 | 0.018 | 0.03 | Purinergic P2X agonist | |||
| 0.014 | 0.002 | 0.014 | Transcortin receptor antagonist | |||
| 0.016 | 0.004 | 0.016 | Thromboxane agonist | |||
| 0.036 | 0.025 | 0.068 | Arginase inhibitor | 0.068 0.008 CID_154699583 | CID_154699583 | |
| 0.053 | 0.042 | 0.053 | Sphingosine kinase 2 inhibitor | |||
| 0.02 | 0.01 | 0.02 | Progesterone agonist | |||
| 0.036 | 0.026 | 0.036 | Glutamate (mGluR3) antagonist | |||
| 0.058 | 0.048 | 0.058 | NMDA 2C receptor antagonist | |||
| 0.04 | 0.031 | 0.04 | Sphingosine kinase 1 inhibitor | |||
| 0.031 | 0.023 | 0.031 | ATP citrate lysase inhibitor | |||
| 0.016 | 0.008 | 0.016 | Antibiotic Tetracycline-like | |||
| 0.023 | 0.015 | 0.023 | Prostaglandin F2 alpha agonist | |||
| 0.036 | 0.03 | 0.036 | Glutamate (mGluR8) agonist | |||
| 0.094 | 0.088 | 0.094 | DOPA decarboxylase inhibitor | |||
| 0.056 | 0.05 | 0.056 | Purinergic P2X1 antagonist | |||
| 0.021 | 0.014 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.037 | 0.031 | 0.037 | GABA uptake inhibitor | |||
| 0.041 | 0.036 | 0.041 | Heme oxygenase inhibitor | |||
| 0.019 | 0.014 | 0.033 | Antibiotic Anthracycline-like | 0.033 0.003 CID_154699583 | CID_154699583 | |
| 0.047 | 0.043 | 0.141 | Protein 50S ribosomal subunit inhibitor | 0.141 0.007 CID_154699583 | CID_154699583 | |
| 0.019 | 0.014 | 0.019 | Progesterone receptor B antagonist | |||
| 0.053 | 0.049 | 0.053 | Biliverdin reductase inhibitor | |||
| 0.016 | 0.013 | 0.016 | 5-Alpha-reductase 1 inhibitor | |||
| 0.015 | 0.012 | 0.015 | Prostacyclin agonist | |||
| 0.011 | 0.01 | 0.011 | Glucocorticoid agonist | |||
| 0.03 | 0.029 | 0.03 | Fumarate hydratase inhibitor | |||
| 0.148 | 0.156 | 0.247 | Cyclic AMP phosphodiesterase inhibitor | 0.247 0.065 CID_154699583 | CID_154699583 | |
| 0.08 | 0.091 | 0.235 | Monophenol monooxygenase inhibitor | 0.235 0.026 CID_154699583 | CID_154699583 | |
| 0.086 | 0.098 | 0.16 | Toll-Like receptor 4 antagonist | 0.16 0.016 CID_154699583 | CID_154699583 | |
| 0.033 | 0.046 | 0.051 | Phosphorylase inhibitor | 0.051 0.029 CID_154699583 | CID_154699583 | |
| 0.017 | 0.031 | 0.074 | Protein 30S ribosomal subunit inhibitor | 0.074 0.004 CID_154699583 | CID_154699583 | |
| 0.029 | 0.043 | 0.087 | Antibiotic Aminoglycoside-like | 0.087 0.004 CID_154699583 | CID_154699583 | |
| 0.108 | 0.122 | 0.18 | Diuretic | 0.18 0.054 CID_154699583 | CID_154699583 | |
| 0.023 | 0.038 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.016 CID_154699583 | CID_154699583 | |
| 0.081 | 0.102 | 0.115 | Protein-tyrosine phosphatase 1B inhibitor | 0.115 0.067 CID_154699583 | CID_154699583 | |
| 0.126 | 0.152 | 0.227 | ATPase inhibitor | 0.227 0.021 CID_154699583 | CID_154699583 | |
| 0.017 | 0.047 | 0.038 | Sodium/glucose cotransporter 2 inhibitor | 0.038 0.009 CID_154699583 | CID_154699583 | |
| 0.004 | 0.034 | 0.019 | Antibiotic Macrolide-like | 0.019 0.007 CID_154699583 | CID_154699583 | |
| 0.018 | 0.053 | 0.033 | Sodium/glucose cotransporter inhibitor | 0.033 0.009 CID_154699583 | CID_154699583 | |
| 0.079 | 0.115 | 0.134 | Beta glucuronidase inhibitor | 0.134 0.034 CID_154699583 | CID_154699583 | |
| 0.125 | 0.161 | 0.231 | Non-steroidal antiinflammatory agent | 0.231 0.051 CID_154699583 | CID_154699583 | |
| 0.079 | 0.124 | 0.118 | Beta amyloid protein antagonist | 0.118 0.069 CID_154699583 | CID_154699583 | |
| 0.042 | 0.089 | 0.066 | Nitric oxide donor | 0.066 0.038 CID_154699583 | CID_154699583 | |
| 0.038 | 0.088 | 0.099 | Heparanase inhibitor | 0.099 0.004 CID_154699583 | CID_154699583 | |
| 0.09 | 0.162 | 0.215 | Cell wall synthesis inhibitor | 0.215 0.025 CID_154699583 | CID_154699583 | |
| 0.12 | 0.209 | 0.282 | Vasodilator | 0.282 0.054 CID_154699583 | CID_154699583 | |
| 0.051 | 0.173 | 0.104 | ATPase (Vacuolar H+) inhibitor | 0.104 0.034 CID_154699583 | CID_154699583 | |
| 0.035 | 0.16 | 0.185 | Topoisomerase II alpha inhibitor | 0.185 0.017 CID_154699583 | CID_154699583 | |
| 0.098 | 0.225 | 0.321 | Platelet antagonist | 0.321 0.046 CID_154699583 | CID_154699583 | |
| 0.039 | 0.177 | 0.211 | Topoisomerase I inhibitor | 0.211 0.024 CID_154699583 | CID_154699583 | |
| 0.022 | 0.162 | 0.344 | Selectin antagonist | 0.344 0.004 CID_154699583 | CID_154699583 | |
| 0.044 | 0.195 | 0.266 | Topoisomerase II inhibitor | 0.266 0.022 CID_154699583 | CID_154699583 | |
| 0.018 | 0.181 | 0.045 | Neuraminidase (Influenza A) inhibitor | 0.045 0.033 CID_154699583 | CID_154699583 | |
| 0.073 | 0.245 | 0.147 | Hexokinase inhibitor | 0.147 0.082 CID_154699583 | CID_154699583 | |
| 0.015 | 0.207 | 0.033 | Toll-Like receptor 4 agonist | 0.033 0.008 CID_154699583 | CID_154699583 | |
| 0.046 | 0.238 | 0.082 | Thioredoxin inhibitor | 0.082 0.077 CID_154699583 | CID_154699583 | |
| 0.032 | 0.228 | 0.061 | Adenine nucleotide translocase inhibitor | 0.061 0.026 CID_154699583 | CID_154699583 | |
| 0.022 | 0.234 | 0.073 | Glucose-6-phosphate translocase inhibitor | 0.073 0.014 CID_154699583 | CID_154699583 | |
| 0.073 | 0.287 | 0.155 | Antiamyloidogenic | 0.155 0.141 CID_154699583 | CID_154699583 | |
| 0.066 | 0.326 | 0.132 | DNA repair enzyme inhibitor | 0.132 0.052 CID_154699583 | CID_154699583 | |
| 0.017 | 0.284 | 0.063 | Neuraminidase (influenza) inhibitor | 0.063 0.047 CID_154699583 | CID_154699583 | |
| 0.062 | 0.347 | 0.208 | Hemostatic | 0.208 0.029 CID_154699583 | CID_154699583 | |
| 0.031 | 0.349 | 0.291 | Thrombolytic | 0.291 0.025 CID_154699583 | CID_154699583 | |
| 0.072 | 0.472 | 0.335 | Immunomodulator | 0.335 0.065 CID_154699583 | CID_154699583 | |
| 0.038 | 0.483 | 0.198 | Insulin secretagoues | 0.198 0.037 CID_154699583 | CID_154699583 | |
| 0.005 | 0.452 | 0.023 | Motilin receptor agonist | 0.023 0.015 CID_154699583 | CID_154699583 | |
| 0.022 | 0.567 | 0.309 | Cell adhesion inhibitor | 0.309 0.009 CID_154699583 | CID_154699583 | |
| 0.016 | 0.601 | 0.137 | Multidrug resistance-associated protein 1 inhibitor | 0.137 0.033 CID_154699583 | CID_154699583 | |
| 0.01 | 0.877 | 0.058 | Factor IXa inhibitor | 0.058 0.028 CID_154699583 | CID_154699583 | |
| 0.005 | 0.887 | 0.169 | Anticoagulant | 0.169 0.067 CID_154699583 | CID_154699583 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |